Skip to main content

LIVE

OverviewAnalystsInstitutionalElite HoldersEarningsNews
EDSA

Edesa Biotech, Inc.

EDSA

NASDAQ·Healthcare·Biotechnology·Mkt cap $45.6M

$4.73

▼ -0.63%

P/E

-3.90

Mkt Cap

$45.6M

52-Wk Range

$0.72–$20.32

52-Week Range

$0.72 - $20.32

P/E

-3.90

Fwd P/E

-2.38

Beta

1.06

Div Yield

0.00%

Avg Vol

215.0K

Shares Out

8.3M

Mkt Cap

$45.6M

Price action

Price chart

Up 95.5% over the trailing year

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

▲

Bull Case

4 reasons

  • Focused pipeline targeting high-unmet-need indications with limited competition
  • Strategic partnerships with specialized biotech firms like NovImmune SA
  • Proprietary monoclonal antibody technology and development expertise
  • Canadian biotech base with access to global clinical trial networks and regulatory pathways
▼

Bear Case

1 risk

  • Average volatility.

Growth

Stable outlook

Phase 3 clinical trial progression and potential regulatory approval of EB05 for ARDS

Value

Deep value opportunity - significant discount to Biotech & Therapeutics peers

Momentum

Weak

-11.9% over 3m

Quality

Loss-making

Mixed fundamentals

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

“
Q3 26 RECAP

AUG 13, 2026

Reported EPS of -$0.60 vs -$0.44 consensus (-37.9% surprise).

EPS miss

EPS surprise · last 4Q

0 of 1 beats

Estimate

Actual

Q3 26

-37.9%

Revenue trend · last 8Q

—

—

—

—

—

—

—

—

Q3 24

Q4 24

Q1 24

Q2 25

Q3 25

Q4 25

Q1 25

Q3 26

$0

$0

$0

$0

$0

$0

$0

$0

Margins · last 8Q

No margin history available.

View full earnings history →

Wall Street consensus

Analyst coverage

Live ratings and price targets aggregated across covering analysts.

View full analyst page →

vs Industry

How EDSA stacks vs Biotechnology

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.